The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II clinical trial of gemcitabine, oxaliplatin, erlotinib combination chemotherapy versus gemcitabine and erlotinib in previously untreated patients with locally advanced or metastatic pancreatic cancer.
 
Sung Hee Lim
No Relationships to Disclose
 
Jina Yun
No Relationships to Disclose
 
Min-Young Lee
No Relationships to Disclose
 
Han Jo Kim
No Relationships to Disclose
 
Kyoung Ha Kim
No Relationships to Disclose
 
Se Hyung Kim
No Relationships to Disclose
 
Sang-Cheol Lee
No Relationships to Disclose
 
Sang Byung Bae
No Relationships to Disclose
 
Chan Kyu Kim
No Relationships to Disclose
 
Namsu Lee
No Relationships to Disclose
 
Kyu Taek Lee
No Relationships to Disclose
 
Sung Kyu Park
No Relationships to Disclose
 
Dae Sik Hong
No Relationships to Disclose
 
Hyun Jong Choi
No Relationships to Disclose
 
Jong Ho Moon
No Relationships to Disclose